Correlation Between Phio Pharmaceuticals and LMF Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Phio Pharmaceuticals and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and LMF Acquisition.

Diversification Opportunities for Phio Pharmaceuticals and LMF Acquisition

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Phio and LMF is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and LMF Acquisition go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and LMF Acquisition

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to generate 6.7 times more return on investment than LMF Acquisition. However, Phio Pharmaceuticals is 6.7 times more volatile than LMF Acquisition Opportunities. It trades about 0.06 of its potential returns per unit of risk. LMF Acquisition Opportunities is currently generating about 0.04 per unit of risk. If you would invest  209.00  in Phio Pharmaceuticals Corp on December 26, 2024 and sell it today you would lose (78.00) from holding Phio Pharmaceuticals Corp or give up 37.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Phio Pharmaceuticals Corp  vs.  LMF Acquisition Opportunities

 Performance 
       Timeline  
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Phio Pharmaceuticals Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Phio Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
LMF Acquisition Oppo 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in LMF Acquisition Opportunities are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent fundamental indicators, LMF Acquisition unveiled solid returns over the last few months and may actually be approaching a breakup point.

Phio Pharmaceuticals and LMF Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phio Pharmaceuticals and LMF Acquisition

The main advantage of trading using opposite Phio Pharmaceuticals and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.
The idea behind Phio Pharmaceuticals Corp and LMF Acquisition Opportunities pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum